{"id":"https://openalex.org/W2185923325","doi":null,"title":"Liposomal formulations of amphotericin B: differences according to the scientific evidence.","display_name":"Liposomal formulations of amphotericin B: differences according to the scientific evidence.","publication_year":2015,"publication_date":"2015-12-01","ids":{"openalex":"https://openalex.org/W2185923325","mag":"2185923325","pmid":"https://pubmed.ncbi.nlm.nih.gov/26621170"},"language":"en","primary_location":{"id":"pmid:26621170","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26621170","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000000103","display_name":"Jos\u00e9 Ram\u00f3n Azanza Perea","orcid":"https://orcid.org/0000-0003-3190-622X","observed_orcids":["https://orcid.org/0000-0003-3190-622X"]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Ram\u00f3n Azanza","raw_affiliation_strings":["Jos\u00e9 Ram\u00f3n Azanza, Servicio de Farmacolog\u00eda Cl\u00ednica Cl\u00ednica Universidad de Navarra, Spain. jrazanza@unav.es"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jos\u00e9 Ram\u00f3n Azanza, Servicio de Farmacolog\u00eda Cl\u00ednica Cl\u00ednica Universidad de Navarra, Spain. jrazanza@unav.es","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007443589","display_name":"Bel\u00e9n S\u00e1dada","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bel\u00e9n S\u00e1dada","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Joana Reis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joana Reis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.7252,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.8264346,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"28","issue":"6","first_page":"275","last_page":"81"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.7074999809265137,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.7074999809265137,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.19509999454021454,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.017899999395012856,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liposomal-amphotericin-b","display_name":"liposomal amphotericin B","score":0.9470000267028809},{"id":"https://openalex.org/keywords/liposomes","display_name":"liposomes","score":0.7680000066757202},{"id":"https://openalex.org/keywords/drug-carriers","display_name":"drug carriers","score":0.8519999980926514},{"id":"https://openalex.org/keywords/liposome-cell-interaction","display_name":"liposome-cell interaction","score":0.8289999961853027},{"id":"https://openalex.org/keywords/liposome-stability","display_name":"liposome stability","score":0.9869999885559082},{"id":"https://openalex.org/keywords/drug-encapsulation","display_name":"drug encapsulation","score":0.8159999847412109},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.9129999876022339},{"id":"https://openalex.org/keywords/generic-drug-development","display_name":"generic drug development","score":0.6370000243186951},{"id":"https://openalex.org/keywords/fda-guidance","display_name":"FDA guidance","score":0.6039999723434448},{"id":"https://openalex.org/keywords/ema-guidelines","display_name":"EMA guidelines","score":0.9959999918937683},{"id":"https://openalex.org/keywords/antifungal-agents","display_name":"antifungal agents","score":0.6959999799728394},{"id":"https://openalex.org/keywords/manufacturing-variability","display_name":"manufacturing variability","score":0.5180000066757202}],"concepts":[{"id":"https://openalex.org/C185154212","wikidata":"https://www.wikidata.org/wiki/Q410454","display_name":"Liposome","level":2,"score":0.9057127833366394},{"id":"https://openalex.org/C2779629538","wikidata":"https://www.wikidata.org/wiki/Q412223","display_name":"Amphotericin B","level":3,"score":0.7064012885093689},{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.5739925503730774},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.535557210445404},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5219019055366516},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.4270900785923004},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3973408639431},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.358362078666687},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3551585078239441},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.3415524959564209},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.18408527970314026},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.14711785316467285},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09960898756980896},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000666","descriptor_name":"Amphotericin B","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000666","descriptor_name":"Amphotericin B","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000666","descriptor_name":"Amphotericin B","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000666","descriptor_name":"Amphotericin B","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D009181","descriptor_name":"Mycoses","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010743","descriptor_name":"Phospholipids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D053835","descriptor_name":"Unilamellar Liposomes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:26621170","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26621170","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia","raw_type":"Journal Article"},{"id":"mag:2185923325","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26621170","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null},{"id":"mag:2788406936","doi":null,"is_oa":false,"landing_page_url":"https://dialnet.unirioja.es/servlet/articulo?codigo=6298758","pdf_url":null,"source":{"id":"https://openalex.org/S976986303","display_name":"Revista espa\u00f1ola de quimioterapia. Suplemento","issn_l":"1130-331X","issn":["1130-331X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Revista espa\u00f1ola de quimioterapia. Suplemento","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2788406936","https://openalex.org/W2310679001","https://openalex.org/W4405535569","https://openalex.org/W3088954208","https://openalex.org/W1579385482","https://openalex.org/W6990082727","https://openalex.org/W2412998811","https://openalex.org/W4250302445","https://openalex.org/W1974939124","https://openalex.org/W3147297797"],"abstract_inverted_index":{"This":[0],"article":[1],"presents":[2],"an":[3,78],"overview":[4],"of":[5,8,19,30,35,52,61,70,87,105,108],"the":[6,41,59,85,93,102,106,113,118],"characteristics":[7],"liposomes":[9,36],"as":[10],"drug":[11],"carriers,":[12],"particularly":[13],"in":[14,56,58,68,112,126,144],"relation":[15],"to":[16,40,46,134],"liposomal":[17,62,89,140],"formulations":[18,90,141],"amphotericin":[20,53,63,138],"B.":[21],"General":[22],"features":[23],"regarding":[24],"structure,":[25],"liposome-cell":[26],"interactions,":[27],"stability,":[28],"encapsulation":[29],"active":[31],"substances":[32],"and":[33,76,95,146],"elimination":[34],"are":[37,97,142],"described.":[38],"Up":[39],"present":[42],"time":[43],"extensive":[44],"efforts":[45],"produce":[47],"similar":[48,74],"or":[49],"bioequivalent":[50],"products":[51],"B":[54,139],"formulations,":[55],"particular":[57],"case":[60],"B,":[64],"have":[65],"been":[66],"unsuccessful":[67],"spite":[69],"having":[71],"a":[72],"very":[73],"composition":[75,107,121],"even":[77,116],"apparently":[79],"identical":[80],"manufacturing":[81,114],"process.":[82],"Guidelines":[83],"for":[84],"development":[86],"generic":[88],"developed":[91],"by":[92],"FDA":[94],"EMA":[96],"also":[98],"summarized.":[99],"Based":[100],"on":[101],"available":[103],"evidence":[104],"liposomes,":[109],"any":[110],"differences":[111],"process":[115],"if":[117],"same":[119],"lipid":[120],"is":[122],"used":[123],"may":[124],"result":[125],"different":[127],"final":[128],"products.":[129],"Therefore,":[130],"it":[131],"seems":[132],"unreasonable":[133],"infer":[135],"that":[136],"all":[137],"equal":[143],"efficacy":[145],"safety.":[147]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}